Tuesday, April 8, 2014

Prebiotics & Probiotics for GI Health and Immune System Functions

Please join us on Tuesday April 15th, 2014 at 4 PM Pacific / 7 PM Eastern as we host Stephen F. Olmstead, MD for a webinar entitled “Prebiotics & Probiotics for GI Health and Immune System Functions”.

Dr. Stephen Olmstead
A diverse, robust gastrointestinal microbiota is essential to the health of our gastrointestinal and immune systems. This webinar will review the critical role the gut microbiota plays in maintaining health. Participants will gain an understanding of how the human intestinal microbiota functions as an organ and is critical for immune and gastrointestinal system maturation, colonization resistance, modulation of immune responses, and nutritional needs. The use of probiotics and prebiotics to support a healthful gut microbiota will be covered in practical details. Probiotics are microorganisms that when consumed provide numerous health benefits. A variety of probiotics are available to health practitioners; most of them are lactic acid bacteria and bifidobacteria. The disorders in which the beneficial use of probiotics is documented include antibiotic-associated GI distress, C. difficile-associated diarrhea, inflammatory bowel disease, irritable bowel disease, dysbiosis, urinary tract infections, allergies, atopic dermatitis, eczema, and lactose intolerance. Multispecies probiotics are generally more effective than single species formulas. Prebiotics increase the numbers and/or activities of healthful gut microbiota. Prebiotics are useful to increase Bifidobacterium populations and to support populations of healthful genera such as Eubacterium and Rosaburia that are not available as probiotics. Participants will learn clinically relevant prebiotic and probiotic interventions that are beneficial for a number of common gastrointestinal and allergic disorders. This presentation will foster an appreciation of the intestinal microbiota and provide participants with the knowledge needed to effectively use prebiotocs and probiotics to enhance health.

Stephen F. Olmstead, MD, is Chief Science Officer at ProThera, Inc. where he directs clinical trials of ProThera® and Klaire Labs™ nutraceutical products. He received his MD from the University of New Mexico in 1979 and completed his Internal Medicine residency at Harvard Medical School, Massachusetts General Hospital in 1982 and fellowship in Cardiovascular Diseases at the University of Washington in 1987. Dr. Olmstead served 2 years in the Commissioned Corps of the US Public Health Service and was stationed primarily at the Indian Health Service Hospital in Gallup New Mexico. For many years, Dr. Olmstead spent his career as a Clinical Assistant Professor in Medicine at the University of Washington Medical School in Seattle. His current research focuses on the use of enzymes and chelating agents to disrupt pathogenic GI biofilm and pre- and probiotics to restore gut microbial balance.

To register for this webinar please click HERE and follow the online registration instructions. 

To hear the webinar, you are given a choice of either listening over your computer speakers or over the phone when you log in. By default, it sets to your computer speakers. You can use a phone to listen in by selecting the phone option when you log on and then by dialing the number, access code and pin that is given on your Webinar Control Panel.  Participants may ask questions by typing them in during the webinar.  Please note:  All audience members are muted by default when they log on.

The webinar will begin promptly at 4:00 PM Pacific, 7:00 PM Eastern and participation is limited to the first 100 Attendees.

The webinar and webinar format is a great opportunity for us to share information resources and learn together in real time.

If you are unable to join during the live presentation, please note that webinars are recorded and many are available to the public. Access them online by Clicking Here. Enrolled students can access all archived webinars via their student portal.